Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-30 9:34 pm Purchase | 2024-12-31 | 13G | Arcellx, Inc. ACLX | VANGUARD GROUP INC | 3,330,092 6.150% | 3,330,092 (New Position) | Filing History |
| 2024-11-22 4:12 pm Purchase | 2024-11-15 | 13G | Arcellx, Inc. ACLX | RA CAPITAL MANAGEMENT L.P. | 2,787,327 5.200% | 2,787,327 (New Position) | Filing History |
| 2024-11-14 4:35 pm Purchase | 2024-09-30 | 13G | Arcellx, Inc. ACLX | Paradigm Biocapital Advisors LP | 4,800,000 8.900% | 1,141,376 (+31.20%) | Filing History |
| 2024-11-14 4:31 pm Sale | 2024-09-30 | 13G | Arcellx, Inc. ACLX | PERCEPTIVE ADVISORS LLC | 3,888,669 7.200% | -656,140 (-14.44%) | Filing History |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | Arcellx, Inc. ACLX | FMR LLC | 6,479,273 12.053% | 1,084,778 (+20.11%) | Filing History |
| 2024-11-08 4:40 pm Purchase | 2024-11-03 | 13D | Arcellx, Inc. ACLX | Elghandour Rami | 2,850,665 5.000% | 2,850,665 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Arcellx, Inc. ACLX | BlackRock Inc. BLK | 4,246,692 7.900% | 0 (Unchanged) | Filing History |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Arcellx, Inc. ACLX | BlackRock Inc. BLK | 4,246,692 7.900% | 1,228,154 (+40.69%) | Filing History |
| 2024-04-10 10:06 am Purchase | 2024-04-09 | 13G | Arcellx, Inc. ACLX | FMR LLC | 5,394,495 10.217% | 1,015,326 (+23.19%) | Filing History |
| 2024-03-25 6:41 pm Sale | 2024-03-21 | 13D | Arcellx, Inc. ACLX | SR ONE CAPITAL MANAGEMENT LLC | 2,346,630 4.440% | -800,000 (-25.42%) | Filing History |
| 2024-02-14 5:57 pm Purchase | 2023-12-31 | 13G | Arcellx, Inc. ACLX | Paradigm Biocapital Advisors LP | 3,658,624 7.000% | 1,235,924 (+51.01%) | Filing History |
| 2024-02-14 4:48 pm Purchase | 2023-12-31 | 13G | Arcellx, Inc. ACLX | PERCEPTIVE ADVISORS LLC | 4,544,809 8.800% | 1,946,504 (+74.91%) | Filing History |
| 2024-02-13 11:50 am Purchase | 2023-12-31 | 13G | Arcellx, Inc. ACLX | SUVRETTA CAPITAL MANAGEMENT LLC | 2,435,974 5.000% | 85,641 (+3.64%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Arcellx, Inc. ACLX | FMR LLC | 4,379,169 8.994% | 4,379,169 (New Position) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Arcellx, Inc. ACLX | BlackRock Inc. BLK | 3,018,538 6.200% | 862,389 (+40.00%) | Filing History |
| 2023-12-28 5:06 pm Purchase | 2023-12-28 | 13G | Arcellx, Inc. ACLX | GILEAD SCIENCES INC. GILD | 6,720,803 12.900% | 3,242,542 (+93.22%) | Filing History |
| 2023-12-18 4:16 pm Sale | 2023-12-14 | 13D | Arcellx, Inc. ACLX | SR ONE CAPITAL MANAGEMENT LLC | 3,146,630 6.460% | -800,000 (-20.27%) | Filing History |
| 2023-07-21 4:44 pm Purchase | 2023-07-11 | 13G | Arcellx, Inc. ACLX | Paradigm Biocapital Advisors LP | 2,422,700 5.050% | 2,422,700 (New Position) | Filing History |
| 2023-06-23 2:31 pm Sale | 2023-06-01 | 13D | Arcellx, Inc. ACLX | New Enterprise Associates 15 L.P. | 3,745,262 7.800% | -1,001,232 (-21.09%) | Filing History |
| 2023-06-02 4:46 pm Sale | 2023-05-31 | 13D | Arcellx, Inc. ACLX | SR ONE CAPITAL MANAGEMENT LLC | 3,946,630 8.220% | -540,544 (-12.05%) | Filing History |